Salsalate is poorly tolerated and fails to improve endothelial function in virologically suppressed HIV-infected adults

AIDS

Volumn 24, Issue 12, 2010, Pages 1958-1961

  Hileman, Corrilynn O ^a   Carman, Teresa L ^a   Gripshover, Barbara M ^a   O'Riordan, Maryann ^a   Storer, Norma J ^a   Harrill, Danielle E ^a   White, Cynthia A ^a   McComsey, Grace A ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SALSALATE;

ABDOMINAL PAIN; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR RISK; DRUG ERUPTION; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; ENDOTHELIUM; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPERTRANSAMINASEMIA; INFLAMMATION; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; THROMBOCYTOPENIA; TINNITUS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRACHIAL ARTERY; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMALE; HIV INFECTIONS; HUMANS; INSULIN RESISTANCE; MALE; SALICYLIC ACIDS;

EID: 77954761898     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32833c3251     Document Type: Article

References (21)

1. Melendez MM, McNurlan MA, Mynarcik DC, Khan S, Gelato MC. Endothelial adhesion molecules are associated with inflammation in subjects with HIV disease. Clin Infect Dis 2008; 46:775-780.
2. Ross AC, Armentrout R, O'Riordan MA, Storer N, Rizk N, Harrill D, et al. Endothelial activation markers are linked to HIV status and are independent of antiretroviral therapy and lipoatrophy. J Acquir Immune Defic Syndr 2008; 49:499-506.
3. Ross AC, Rizk N, O'Riordan MA, Dogra V, El-Bejjani D, Storer N, et al. Relationship between inflammatory markers, endothe-lial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy. Clin Infect Dis 2009; 49:1119-1127.
4. Brown TT, Tassiopoulos K, Shikuma C, McComsey GA. Higher markers of TNF-a activity 48 weeks after ART-initiation are associated with incident diabetes mellitus in the ACTG/ALLRT cohort: a nested case-control study. In: Program and Abstracts of the 11th International Workshop on Adverse Drug Reactions and Co-morbidities in HIV; Philadelphia, Pennsylvania, USA; 26-28 October 2009.
5. Kopp E, Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 1994; 265:956-959.
6. Barnes PJ, Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997; 336:1066-1071.
7. Brasier AR. The NF-kappaB regulatory network. Cardiovasc Toxicol 2006; 6:111-130.
8. Demarchi F, d'Adda di Fagagna F, Falaschi A, Giacca M. Activation of transcription factor NF-kappaB by the Tat protein of human immunodeficiency virus type 1. J Virol 1996; 70:4427-4437.
9. Roux P, Alfieri C, Hrimech M, Cohen EA, Tanner JE. Activation of transcription factors NF-kappaB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces inter-leukin-8 expression. J Virol 2000; 74:4658-4665.
10. Fleischman A, Shoelson SE, Bernier R, Goldfine AB. Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care 2008; 31:289-294.
11. Goldfine AB, Silver R, AldhahiW, Cai D, Tatro E, Lee J, Shoelson SE. Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes. Clin Transl Sci 2008; 1:36-43.
12. Solovey AA, Solovey AN, Harkness J, Hebbel RP. Modulation of endothelial cell activation in sickle cell disease: a pilot study. Blood 2001; 97:1937-1941.
13. Gupta SK, Johnson RM, Saha C, Mather KJ, Greenwald ML, Waltz JS, et al. Improvement in HIV-related endothelial dysfunction using the anti-inflammatory agent salsalate: a pilot study. AIDS 2008; 22:653-655.
14. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39:257-265.
15. Gonzalez AS, Kostine A, Gomez-Flores JR, Marquez MF, Hermosillo AG, Paris JV, et al. Non-invasive assessment of endothelial function: intra and inter-observer variability. Arch Cardiol Mex 2006; 76:397-400.
16. Takase B, Uehata A, Akima T, Nagai T, Nishioka T, Hamabe A, et al. Endothelium-dependent flow-mediated vasodilation in coronary and brachial arteries in suspected coronary artery disease. Am J Cardiol 1998; 82:1535-1539; A7-A8.
17. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362:801-809.
18. Torriani FJ, Komarow L, Parker RA, Cotter BR, Currier JS, Dube MP, et al. Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: the ACTG (AIDS Clinical Trials Group) study 5152s. J Am Coll Cardiol 2008; 52:569-576.
19. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419.
20. Koh KK, Cardillo C, Bui MN, Hathaway L, Csako G, Waclawiw MA, et al. Vascular effects of estrogen and cholesterol-lowering therapies in hypercholesterolemic postmenopausal women. Circulation 1999; 99:354-360.
21. de Kleijn MJ, Wilmink HW, Bots ML, Bak AA, van der Schouw YT, Planellas J, et al. Hormone replacement therapy and en-dothelial function: results of a randomized controlled trial in healthy postmenopausal women. Atherosclerosis 2001; 159: 357-365.